Expand RADX Menu
RADX MENU

RADX Latest Press Releases

-- April 23, 2026 --

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026 Globe Newswire 8:35 AM
Radiopharm Theranostics Reports Business Update Globe Newswire 7:00 AM

-- April 20, 2026 --

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026 Globe Newswire 7:00 AM

-- April 16, 2026 --

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases Globe Newswire 7:00 AM

-- April 8, 2026 --

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial Globe Newswire 7:00 AM

-- April 7, 2026 --

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S. Globe Newswire 7:00 AM

-- March 27, 2026 --

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer Globe Newswire 7:00 AM

-- March 24, 2026 --

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases Globe Newswire 7:00 AM

-- February 24, 2026 --

Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01) Globe Newswire 7:30 AM

-- January 28, 2026 --

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates Globe Newswire 7:00 AM

-- January 21, 2026 --

Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream Globe Newswire 7:00 AM

-- January 20, 2026 --

Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream Globe Newswire 7:00 AM

-- January 12, 2026 --

RAD Increases Ownership in Radiopharm Ventures to 87.5% Globe Newswire 7:00 AM

-- December 15, 2025 --

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes